Biao F. Huang - Publications

A homogeneous immunoassay based on AlphaLICA technology for detecting florfenicol residues in animal-derived foods.

Journal: Analytical methods : advancing methods and applications

Published: September 01, 2026

Development and preliminary clinical application of a time-resolved fluoroimmunoassay for anti-rituximab antibodies in membranous nephropathy.

Journal: Bioanalysis

Published: June 25, 2026

Protocadherin 7 Positive Membranous Nephropathy in China.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: May 22, 2026

Detection of kanamycin residues in animal-derived foods using a homogeneous AlphaLICA immunoassay.

Journal: Analytical methods : advancing methods and applications

Published: May 22, 2026

Sensitive amplified luminescent proximity homogeneous assay for the quantitative detection of growth differentiation factor 15 and its application in cardiovascular disease.

Journal: Bioanalysis

Published: May 21, 2026

Development of a Time-Resolved Fluorescence Immunoassay for BAFF and Its Preliminary Clinical Application in Patients with Lupus Nephritis.

Journal: Journal of fluorescence

Published: May 05, 2026

Efficacy and safety of anti-CLDN18.2 therapies in advanced or metastatic gastric, gastro-oesophageal junction, and oesophageal carcinomas with CLDN18.2 positivity: a systematic review and meta-analysis.

Journal: Future oncology (London, England)

Published: April 16, 2026

Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 13, 2026

AlphaLICA-based homogeneous immunoassay for highly sensitive detection of streptomycin in infant formula.

Journal: Analytical methods : advancing methods and applications

Published: February 19, 2026

Diagnostic performance of time-resolved fluoroimmunoassay based anti-phospholipase A2 receptor antibody detection for primary membranous nephropathy.

Journal: Scientific reports

Published: February 13, 2026

Beyond Monotherapy: The Evolving Role of CTLA-4 in Combination Immunotherapy for Gastrointestinal Cancers.

Journal: The American journal of the medical sciences

Published: February 02, 2026

Serum PLA2R-IgG4/PLA2R-IgG ratio dynamics reveal pathogenic autoantibody subclass switch during progression of PLA2R-associated membranous nephropathy.

Journal: Annals of medicine

Published: January 06, 2026